• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎住院患者和门诊患者中的严重急性呼吸综合征冠状病毒2病毒脱落及相关因素

SARS-CoV-2 Viral Shedding and Associated Factors among COVID-19 Inpatients and Outpatients.

作者信息

Sofian Masoomeh, Khansarinejad Behzad, Ghaznavi-Rad Ehsanollah, Shokoohi Farzaneh, Mazaherpour Hossein, Farmani Farzane, Sadat Larijani Mona, Pakpour Leila, Ramezani Amitis

机构信息

Infectious Disease Research Center (IDRC), Arak University of Medical Science, Arak, Iran.

Department of Microbiology and Immunology, Arak University of Medical Sciences, Arak, Iran.

出版信息

Interdiscip Perspect Infect Dis. 2022 Jun 12;2022:1411106. doi: 10.1155/2022/1411106. eCollection 2022.

DOI:10.1155/2022/1411106
PMID:35734510
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9207016/
Abstract

BACKGROUND

According to the contagious ability of the new virus, SARS-CoV-2, characterization of viral shedding duration in the period of infection is highly valuable in terms of providing quarantine guidelines and isolation policies. Therefore, we aimed at viral shedding determination in 58 COVID-19 confirmed Iranian subjects in different stages.

METHODS

58 COVID-19 confirmed Iranian subjects including 21 outpatients and 37 inpatients were investigated. The analytical data and clinical properties were documented in the standard questionnaire. The RT-PCR tests were done two and three weeks after the symptoms initiation.

RESULTS

Viral eradication occurred in 44.8% two weeks after illness initiation whereas in 71% who achieved a negative PCR test in the third week. Moreover, prolonged viral shedding was observed in hospitalized cases in comparison to outpatients. Almost 30% of patients continued viral shedding three weeks after disease initiation.

CONCLUSION

A longer duration of viral shedding in hospitalized cases rather than outpatients was observed in this study. The results similar to other investigations call into question if the current policies are enough to prevent the viral spread or not. This study should be done on a larger sample to provide an appropriate time in isolation policy.

摘要

背景

根据新型冠状病毒SARS-CoV-2的传播能力,确定感染期间病毒脱落持续时间对于制定隔离指南和隔离政策具有重要价值。因此,我们旨在确定58名确诊为COVID-19的不同阶段伊朗患者的病毒脱落情况。

方法

对58名确诊为COVID-19的伊朗患者进行了调查,其中包括21名门诊患者和37名住院患者。分析数据和临床特征记录在标准问卷中。在症状出现后两周和三周进行逆转录聚合酶链反应(RT-PCR)检测。

结果

发病后两周,44.8%的患者病毒清除,而在第三周PCR检测呈阴性的患者中这一比例为71%。此外,与门诊患者相比,住院患者的病毒脱落时间延长。近30%的患者在发病三周后仍有病毒脱落。

结论

本研究观察到住院患者的病毒脱落持续时间比门诊患者更长。与其他研究结果相似,这引发了对当前政策是否足以防止病毒传播的质疑。本研究应扩大样本量,以确定合适的隔离时间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8052/9207016/7802bf81b30e/IPID2022-1411106.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8052/9207016/7802bf81b30e/IPID2022-1411106.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8052/9207016/7802bf81b30e/IPID2022-1411106.001.jpg

相似文献

1
SARS-CoV-2 Viral Shedding and Associated Factors among COVID-19 Inpatients and Outpatients.新型冠状病毒肺炎住院患者和门诊患者中的严重急性呼吸综合征冠状病毒2病毒脱落及相关因素
Interdiscip Perspect Infect Dis. 2022 Jun 12;2022:1411106. doi: 10.1155/2022/1411106. eCollection 2022.
2
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
3
Estimation of shedding time in laboratory-confirmed COVID-19 cases in South Africa: a population-based record linkage study, March-December 2020.南非基于人群的病例关联研究估算实验室确诊的 2019 冠状病毒病病例的脱落时间:2020 年 3 月至 12 月。
Pan Afr Med J. 2023 Sep 15;46:24. doi: 10.11604/pamj.2023.46.24.41047. eCollection 2023.
4
Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.糖尿病是危重症患者下呼吸道样本中 SARS-CoV-2 病毒持续脱落的一个风险因素。
Endocrine. 2020 Dec;70(3):454-460. doi: 10.1007/s12020-020-02465-4. Epub 2020 Sep 1.
5
Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular Assay.通过改良型商用快速分子检测评估口咽拭子中 SARS-CoV-2 的脱落频率和持续时间。
Viruses. 2020 Oct 20;12(10):1184. doi: 10.3390/v12101184.
6
SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series.隔离一艘游轮上的乘客后,其体内的 SARS-CoV-2 脱落和血清转化:一项病例系列研究。
Lancet Infect Dis. 2020 Sep;20(9):1051-1060. doi: 10.1016/S1473-3099(20)30364-9. Epub 2020 Jun 12.
7
Recurrent SARS-CoV-2 RNA positivity and prolonged viral shedding in a patient with COVID-19: a case report.COVID-19 患者复发性 SARS-CoV-2 RNA 阳性和病毒持续排出:一例病例报告。
BMC Infect Dis. 2021 Oct 18;21(1):1076. doi: 10.1186/s12879-021-06776-3.
8
SARS-CoV-2 is associated with high viral loads in asymptomatic and recently symptomatic healthcare workers.SARS-CoV-2 与无症状和近期有症状的医护人员的高病毒载量有关。
PLoS One. 2021 Mar 18;16(3):e0248347. doi: 10.1371/journal.pone.0248347. eCollection 2021.
9
Prolonged SARS-Cov-2 shedding with rapid IgG antibody decay in a COVID-19 patient: A case report.SARS-CoV-2 持续排出伴 COVID-19 患者 IgG 抗体快速衰减:一例报告。
J Clin Lab Anal. 2021 Nov;35(11):e24002. doi: 10.1002/jcla.24002. Epub 2021 Sep 15.
10
Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).2019冠状病毒病(COVID-19)患者病毒RNA长期脱落的相关因素
Clin Infect Dis. 2020 Jul 28;71(15):799-806. doi: 10.1093/cid/ciaa351.

引用本文的文献

1
Estimation of shedding time in laboratory-confirmed COVID-19 cases in South Africa: a population-based record linkage study, March-December 2020.南非基于人群的病例关联研究估算实验室确诊的 2019 冠状病毒病病例的脱落时间:2020 年 3 月至 12 月。
Pan Afr Med J. 2023 Sep 15;46:24. doi: 10.11604/pamj.2023.46.24.41047. eCollection 2023.
2
Evaluation of PastoCovac plus vaccine as a booster dose on vaccinated individuals with inactivated COVID-19 vaccine.评估PastoCovac加强疫苗对已接种新冠病毒灭活疫苗个体的效果。
Heliyon. 2023 Sep 29;9(10):e20555. doi: 10.1016/j.heliyon.2023.e20555. eCollection 2023 Oct.
3
PastoCovac and PastoCovac Plus as protein subunit COVID-19 vaccines led to great humoral immune responses in BBIP-CorV immunized individuals.

本文引用的文献

1
SARS-CoV-2 re-infection rate in Iranian COVID-19 cases within one-year follow-up.在伊朗 COVID-19 病例为期一年的随访中,SARS-CoV-2 再感染率。
Microb Pathog. 2021 Dec;161(Pt B):105296. doi: 10.1016/j.micpath.2021.105296. Epub 2021 Nov 18.
2
Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID-19 patients.无症状 SARS-CoV-2 携带者和有症状/症状前 COVID-19 患者的流行病学特征、病毒脱落和抗体血清转换。
J Infect Public Health. 2021 Jul;14(7):845-851. doi: 10.1016/j.jiph.2021.05.003. Epub 2021 May 27.
3
Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses.
巴斯德科瓦克和巴斯德科瓦克加作为蛋白质亚单位 COVID-19 疫苗,在 BBIP-CorV 免疫个体中引起了强烈的体液免疫反应。
Sci Rep. 2023 May 18;13(1):8065. doi: 10.1038/s41598-023-35147-y.
住院 COVID-19 患者的传染性 SARS-CoV-2 脱落与血清抗体反应的关系。
BMC Infect Dis. 2021 May 27;21(1):494. doi: 10.1186/s12879-021-06202-8.
4
SARS-CoV-2 presented moderately during two episodes of the infection with lack of antibody responses.SARS-CoV-2 在两次感染过程中表现为中度,抗体反应缺乏。
Virus Res. 2021 Jul 2;299:198421. doi: 10.1016/j.virusres.2021.198421. Epub 2021 Apr 6.
5
Prolonged viral shedding and antibody persistence in patients with COVID-19.COVID-19 患者的病毒持续排出和抗体持续存在。
Microbes Infect. 2021 May-Jun;23(4-5):104810. doi: 10.1016/j.micinf.2021.104810. Epub 2021 Mar 17.
6
Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran.再感染与再激活的 SARS-CoV-2 的临床特征:来自伊朗的病例系列。
Eur J Clin Microbiol Infect Dis. 2021 Aug;40(8):1713-1719. doi: 10.1007/s10096-021-04221-6. Epub 2021 Mar 18.
7
Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19.基于 SARS-CoV-2 的生物信息学分析以寻找针对 COVID-19 的有效疫苗候选物。
Mol Biotechnol. 2021 May;63(5):389-409. doi: 10.1007/s12033-021-00303-0. Epub 2021 Feb 24.
8
SARS-CoV‑2, a virus with many faces: a series of cases with prolonged persistence of COVID-19 symptoms.SARS-CoV-2,一个多面的病毒:一系列 COVID-19 症状持续时间延长的病例。
Wien Med Wochenschr. 2021 Feb;171(1-2):3-6. doi: 10.1007/s10354-020-00793-8. Epub 2020 Dec 14.
9
Temporal profile and determinants of viral shedding and of viral clearance confirmation on nasopharyngeal swabs from SARS-CoV-2-positive subjects: a population-based prospective cohort study in Reggio Emilia, Italy.意大利雷焦艾米利亚基于人群的前瞻性队列研究:SARS-CoV-2 阳性者鼻咽拭子中病毒脱落的时间特征和决定因素及病毒清除确认。
BMJ Open. 2020 Sep 2;10(8):e040380. doi: 10.1136/bmjopen-2020-040380.
10
Persistent viral RNA shedding after COVID-19 symptom resolution in older convalescent plasma donors.COVID-19 症状缓解后老年恢复期血浆供者持续的病毒 RNA 脱落。
Transfusion. 2020 Oct;60(10):2189-2191. doi: 10.1111/trf.15927. Epub 2020 Jun 24.